• Decidua;
  • galectins;
  • matrix metalloproteinases;
  • signal transducer and activator of transcription 3;
  • tissue inhibitors of metalloproteinases;
  • trophoblast cells;
  • Wnt signalling


  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

Citation Fitzgerald JS, Germeyer A, Huppertz B, Jeschke U, Knöfler M, Moser G, Scholz C, Sonderegger S, Toth B, Markert UR. Governing the invasive trophoblast: current aspects on intra- and extracellular regulation. Am J Reprod Immunol 2010

This review summarizes several aspects especially of regulating factors governing trophoblast invasion. Those include the composition of the extracellular matrix containing a variety of matrix metalloproeinases and their inhibitors, but also intracellular signals. Furthermore, a newly described trophoblast subtype, the endoglandular trophoblast, is presented. Its presence may provide a possible mechanism for opening and connecting uterine glands into the intervillous space. Amongst others, two intracellular signalling pathways are crucial for regulation of trophoblast functions and development: Wnt- and signal transducer and activator of transcription (STAT)3 signalling. Wnt signalling promotes implantation, placentation and trophoblast differentiation. Several Wnt-dependent cascades and regulatory mechanisms display different functions in trophoblast cells. The STAT3 signalling system is fundamental for induction and regulation of invasiveness in physiological trophoblastic cells, but also in tumours. The role of galectins (Gal) in trophoblast regulation and placenta development comes increasingly into focus. The Gal- 1–4, 7–10 and 12–14 have been detected in humans. Detailed information is only available for Gal-1, -2, -3, -4, -9 and -12 in endometrium and decidua. Gal-1, -3 and -13 (-14) have been detected and studied in trophoblast cells.


  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

Trophoblast cells are a very heterogenous cell type that display manifold basic and fundamental functions during the development of the placenta. Trophoblast cells cannot only be divided into villous and extravillous cells or into cells responsible for exchange of metabolic products and anchoring cells. Trophoblast cells invade the decidua where they possess a variety of capacities: communication with maternal immune cells, hormone and cytokine production, substitution of endothelial cells of maternal arterioles, angiogenesis, fusion to giant cells and recent studies insinuate substitution of glandular epithelium. The regulation of these features depends upon plentiful extra- and intracellular signals, a few prominent of which have been briefly described in this review.

Extracellular matrix (ECM)

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

The maternal ECM within the endometrium consists of several compounds such as fibronectin, fibrin, vitronectin, and laminin.1 During the implantation process, trophoblast cells express mediators facilitating attachment and degradation of the ECM to be able to invade the endometrium and reach the maternal blood supply.2 Along with other well-known mediators such as hormones, growth factors and cytokines, several integrins [e.g. integrin alpha(IIb) beta(3)] facilitate the anchoring of the trophoblast to fibrin.3 While integrin alpha(5) beta(1) improves the attachment to fibronectin of maternal origin, other integrins, such as integrin alpha(4) beta(4), are downregulated during the implantation process.4 However, integrin expression is also present on endometrial cells, particularly integrin alpha(v) beta(3) and alpha(4) beta(1).5

The expression of proteinases such as matrix metalloproteinases (MMPs) remains crucial for the invasion potential of trophoblast cells and contributes to the degradation of the ECM, while tissue inhibitors of metalloproteinases (TIMPs) act as counterparts and limit the invasion process.6

During the ‘window of implantation’, expression of MMPs and other invasion factors is tightly regulated by a bidirectional foeto-maternal cross-talk involving chemokines, cytokines and growth factors expressed by endometrial cells that contribute to a paracrine change in the gene expression profile of the trophoblast.7

CX3CL1 and CCL14, two cytokines produced by endometrial decidual cells, are found to regulate trophoblast gene expression, including MMP-12, integrin beta(5) and osteopontin, leading to an increased trophoblast adhesion to fibronectin.8 Furthermore, MMP-12 is known to degrade many components found at the implantation site, such as type IV collagen, laminin, fibronectin, vitronectin, myelin basic protein and chondroitin sulphate. Additionally, MMPs are expressed on trophoblast cells in a time-dependent manner, with a dominant expression of MMP-2 [one of the key enzymes (gelatinase) for trophoblast invasion] during the early phase of implantation followed by MMP-9 expression that is essential for the invasiveness of the trophoblast. Both MMP genes are shown to be stimulated by epidermal growth factor and forskolin in vitro.9 Furthermore, interleukins (IL), such as IL-1beta and IL-6, stimulate the autocrine production of MMP-9 within trophoblasts,10,11 while IL-10 inhibits MMP production.12

Leukaemia inhibitory factor (LIF), another cytokine of endometrial origin, increases trophoblast invasion by downregulating integrin beta(4) and by enhancing the potential of trophoblast cells to adhere to ECM components (such as fibronectin, vitronectin and laminin) in vitro.13 This cytokine is also able to regulate TIMP expression, but not MMP expression, and therefore may be capable of controlling trophoblast invasion in human pregnancy.13

Finally, the ECM itself regulates the expression of different MMPs within the trophoblast.14

Role of galectins in trophoblast invasion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

Galectin (Gal) is a general name proposed in 1994 for a family of animal lectins.15 Gals are defined as lectins having both galactose-binding ability and amino-acid sequences that characterize Gals.16 Gals are members of the mammalian β-galactoside-binding proteins and recognize Galβ1-4GlcNAc sequences of several cell surface oligosaccharides (Fig. 1a).17–19 Gal-1 binds preferentially to the Thomsen–Friedenreich (TF) antigen (Galβ1-3GalNAc) on placental cells (Fig. 1b).20–22 At the moment, 15 different Gals are under investigation. There is evidence that Gal 1–4, 7–10 and 12–14 are present in humans, whereas Gal-5, -6 or -11 cannot be detected. Gal-5 is only present in rats and Gal-6 only in mice. Gal-11 has been used as an alternative name for two non-human Gal-like proteins. Gal-15 is expressed in the uteri of sheep, cow and goat.


Figure 1.  (a) Structure of N-acetyl-lactose. (b) Structure of the Thomsen–Friedenreich antigen.

Download figure to PowerPoint

Gal-1 regulates cell apoptosis, cell differentiation and hormone production. It binds TF, CD45, CD95, CD3 and CD4 and inhibits CD45 protein phosphatase activity.20,22–25 On trophoblast cells Gal-1 induces phosphorylation of vascular endothelial growth factor receptor 3 and inhibits phosphorylation of rearranged during transfection and Janus Kinase (JAK)2.26 Experiments in mice showed that Gal-1 prevents foetal loss and restored foetal tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which promoted the expansion of IL-10-secreting regulatory T cells in vivo.27 Gal-1 is a pivotal regulator of the fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.28 Gal-1 may also promote NK cell licensing towards pregnancy protection on the level of progenitor cells.29

Gal-2 binds to beta1 integrins on T cells (or a closely associated glycoprotein). The carbohydrate-dependent binding of Gal-2 induces apoptosis in activated T cells.30–33

Gal-3 consists of carbohydrate recognition and collagen-like domains. It is a mediator/modulator of cell to ECM adhesive interactions. Cells, particularly epithelial cells that lack Gal-3 expression, interact poorly with their extracellular matrices. Gal-3 has also been identified in the human placenta, and its abundance was found to be inversely correlated with trophoblast invasiveness during the course of gestation.34 Up-regulation of Gal-3 in both pre-eclamptic and Hemolytic anemia Elevated Liver enzymes and Low Platelet count extravillous trophoblast (EVT) may compensate for the reduced trophoblast invasion observed in both types of pathologic pregnancies.35–39

Gal-4 binds to glycosphingolipids.40,41 Furthermore, Gal-4 promotes adhesion of human colon adenocarcinoma cells. Sulphated glycosphingolipids (SB1a) and carcino embryonic antigen on the cell surface of these cells could be biologically important ligands for Gal-4.40

Gal-7 is associated with the differentiation and development of epithelia. It is also associated with epithelial cell migration. In addition, Gal-7 is designated as the product of the p53-induced gene 1 and is a regulator of apoptosis through c-Jun N-terminal kinases activation and mitochondrial cytochrome c release. It also acts as a transcriptional regulator via its interaction with Smad3.42–45

Gal-8 has a di- or multi-valent structure. This is essential for the induction of cell adhesion and exhibits broad specificity for leukocytes. The Gal-8-induced cell adhesion is accompanied by stress fibre formation, which suggests that intracellular signalling is required. The phosphorylation of proline-rich tyrosine kinase and extracellular signal-regulated kinase (ERK)1/2, indicators of integrin-mediated signalling, was up-regulated on treatment with Gal-8. A primary target of Gal-8 could be the sugar chains on members of the integrin family, which are abundantly expressed on the surface of leukocytes.46–50

Gal-9 is able to induce decreased levels of pro-inflammatory cytokines such as IL-17, IL-12 and IFNγ. Gal-9 decreases numbers of CD4(+) TIM-3(+) T cells in peripheral blood. Gal-9-deficient mice showed increased numbers of CD4(+) TIM-3(+) T cells and decreased numbers of Treg cells. Gal-9 induces differentiation of naive T cells to Treg cells.51–56

Gal-10 is constitutively expressed in human CD25(+) Treg cells, while it is nearly absent in resting and activated CD4(+) T cells. Gal-10 was found to be essential for the functional properties of CD25(+) Treg cells.57,58

Gal-12 is preferentially expressed in peripheral blood leukocytes and adipocytes. Previously, it was shown that Gal-12 is induced by cell cycle block at the G(1) phase and causes G(1) arrest when overexpressed. Gal-12 is required for signal transduction and induction of adipogenic factors essential for adipocyte differentiation.59,60

Gal-13 is also known as Placental Protein 13 (PP13) and was cloned from human term placenta. It shows weak lysophospholipase activity. N-acetyl-lactosamine, mannose and N-acetyl-glucosamine residues had the strongest binding affinity to Gal-13, which also lead to agglutination of erythrocytes. Gal-13 is a homodimer of 16-kDa subunits linked together by disulphide bonds. Strong Gal-13 labelling of the syncytiotrophoblasts confirmed its galectin-like externalization to the cell surface. PP13/galectin 13 may have special haemostatic and immunobiological functions in the placenta. In addition, first trimester PP-13 levels may be useful in predicting pre-eclampsia, and the accuracy of the method increases when coupled with second trimester Doppler measurement.57,61,62

Gal-14 is known as PP13-like (Charcot–Leyden crystal protein 2). It is highly expressed in the human placenta and contains one galectin domain. Less is known about the function of this protein.63–66

The role of Wnt signalling in trophoblast invasion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

Wnt (Wingless)-dependent signalling cascades play fundamental roles during embryonic development, tissue homeostasis and progression of cancer.67,68 They affect numerous key cellular processes such as primary axis formation, maintenance of intestinal stem cells or axon guidance by controlling proliferation, differentiation and cell motility. The Wnt ligands are glycoproteins acting through different signalling pathways of which the canonical Wnt β-catenin-dependent pathway has been extensively analysed.69

In canonical Wnt signalling, Wnt ligands interact with a heterodimeric receptor consisting of lipoprotein receptor-related protein-5 or -6 (LRP-5/6) and a seven transmembrane Frizzled (Fzd) protein. To date, 19 different Wnt ligands and 10 different Fzd receptors have been described. Formation of the Wnt/LRP-5/6/Fzd complex activates Dishevelled, a critical signalling molecule of both canonical and non-canonical Wnt pathways, and induces recruitment of Axin, a negative regulator of β-catenin stability, to the cytosolic portion of LRP-5/6. In the absence of a Wnt signal Axin together with adenomatous polyposis coli (APC), casein kinase Iα and glycogen synthase kinase 3β (GSK3β) form the so-called β-catenin destruction complex promoting phosphorylation and continuous degradation of β-catenin through a proteasomal pathway. However, receptor binding of Wnt inhibits β-catenin degradation through a series of events resulting in cytosolic accumulation of the protein and translocation to the nucleus. Within the nucleus, β-catenin acts as a transcriptional co-activator of particular DNA-binding proteins, the T-cell-specific factor (TCF)/lymphoid enhancer-binding factor 1 (LEF1) transcription factor family.70 Upon binding, β-catenin displaces transcriptional inhibitors, such as Groucho proteins, from TCFs and recruits co-activators such as histone acetylases and the Legless family docking protein BCL9. TCF/β-catenin complexes finally promote transcription of genes controlling cell proliferation and migration/invasion, such as cyclin D,71 c-myc 72 and MMPs.73 Mutations in the critical Wnt components APC, Axin and β-catenin are frequently found in tumours mainly provoking abnormal stabilization and nuclear abundance of β-catenin.74 Beside the canonical pathway, Wnts may signal through a variety of other downstream effectors, commonly known as non-canonical Wnt pathways. In the Wnt-planar cell polarity pathway, non-canonical Wnts such as Wnt-5a or Wnt-11 provoke cell polarity and movement, through Rho GTPases such as RhoA and Rac,75 whereas the Wnt-Ca2+ pathway was shown to activate protein kinase C and calcium–calmodulin-dependent kinase II.76 Ligands such as Wnt-3A may also activate other β-catenin-independent signalling cascades such as ERK or protein kinases B (AKT).77,78

Accumulating evidence suggests that Wnt signalling is also critically involved in implantation and placental development. In mice, various Wnts and Fzds were detected at the time of implantation,79 and blastocyst attachment was shown to induce endometrial Wnt-4 expression.80 Accordingly, blocking of the canonical Wnt pathway with the soluble inhibitors secreted frizzled-related protein 2 (sFRP-2)81 or Dickkopf-1 (Dkk1),82 which blocks Wnt signalling upon binding to LRP-5/6, impaired frequency of mouse implantation.

In humans, endometrial cells were shown to produce Wnt ligands and Dkk1 in a menstrual cycle–dependent manner.83 Also, Dkk1 had been identified as a progesterone-regulated gene.84 In addition, incubation of decidualized stromal cells with trophoblast supernatants resulted in the induction of Wnt signalling genes.85 Hence, similar to mice, Wnt signalling could be an essential part of the human decidual response to the implanting blastocyst.

With respect to placenta formation, gene knock-out (ko) of the ligands Wnt-2, Wnt-7b and of TCF-1/LEF-1 affected critical steps of murine extraembryonic development such as chorion-allantoic fusion or placental vascularization.86–88 Moreover, Wnt signalling may play a critical role in trophoblast development because Wnt-3A was shown to promote trophectoderm formation in embryonic stem cells by inducing the critical transcription factor Cdx2 in a LEF-1-dependent manner.89

However, Wnt signalling may not be only required for early trophoblast lineage determination but also control function of differentiated trophoblast subtypes, such as the invasive, EVT. Recent studies identified nuclear β-catenin in a subset of EVT in vivo as well as in vitro after outgrowth from chorionic villous explant cultures.90 Interestingly, TCF-3 and TCF-4 were also mainly detected in EVT, the latter being almost exclusively expressed in non-proliferating p57/KIP2-positive trophoblasts. Hence, TCF-4 could be an essential transcription factor maintaining the differentiated EVT phenotype. Upon stimulation with the recombinant Wnt ligand Wnt-3A, elevated migration and invasion of primary trophoblasts and the EVT cell line SGHPL-5 could be observed. Similarly, Wnt-3A increased trophoblast outgrowth from villous explant cultures and provoked phosphorylation of AKT in primary EVT and SGHPL-5 cells.91 Dkk1 did not inhibit AKT phosphorylation, suggesting that a classical LRP-5/6-Fzd receptor is not involved in activation of the particular kinase. In other cells, AKT can induce canonical Wnt signalling by phosphorylation/inactivation of GSK-3β and subsequent accumulation of β-catenin.92 However, this cross-talk may not exist in trophoblasts because chemical inhibition of AKT neither increased nuclear abundance of β-catenin nor luciferase activity of a canonical Wnt reporter. However, stimulation of both pathways (non-canonical and AKT) provoked Wnt-dependent secretion of MMP-2, which could be one of the critical Wnt targets promoting trophoblast invasion.91 Dkk-1 treatment of primary trophoblasts and SGHPL-5 not only abolished Wnt-3A-dependent cell motility but also reduced basal migration and invasion, suggesting expression of endogenous Wnt ligands that may act in a autocrine manner. Indeed, 14 of 19 Wnt ligands and 8 of 10 Fzd receptors could be detected in human placenta.93 Interestingly, gestation-dependent as well as trophoblast subtype-specific expression of Wnts and Fzds were noticed. For example, Wnt-1, Wnt-7A, Wnt-10A and Wnt-10B were strongly expressed in first trimester trophoblasts but largely absent from term trophoblasts, indicating that they could mainly play a role in early pregnancy. Wnt-1 and Wnt-2B were abundantly expressed in EVT suggesting that these Wnts could be the prime regulators of Wnt-dependent trophoblast invasiveness. In addition to Wnts, however, other ligands and receptors may contribute to β-catenin/TCF-dependent signalling. For example, gene silencing of protease-activated receptor-1, PAR1, provoked β-catenin destabilization and reduced trophoblast motility.94

The role of Wnt signalling in trophoblast invasion is further emphasized by the fact that promoters of some Wnt inhibitors such as sFRP-2 were shown to be methylated in first trimester trophoblasts potentially leading to their reduced expression and activation of Wnt signalling.95 Interestingly, these genes are hypermethylated in choriocarcinomas, which may correlate with further gene silencing and Wnt-dependent progression of trophoblast towards a malign phenotype. Similar to tumour cells, elevated nuclear expression of β-catenin was observed in invasive trophoblasts of complete hydatidiform mole placentae suggesting that aberrant Wnt signalling could also play a role in the particular gestational disease.90 Moreover, Wnts may also modulate other trophoblast processes such as phospholipid uptake and transport. StarD7, a member of the StAR1 lipid transfer proteins, was identified as direct target gene of TCF/βcatenin in trophoblasts.96

In conclusion, Wnt signalling has been identified as an essential signalling pathway promoting implantation, placentation and trophoblast differentiation. Despite the facts that several Wnt-dependent cascades and regulatory mechanisms have been elucidated, much remains to be learned about putative trophoblast subtype-specific roles of Wnts, their respective receptors interactions and critical downstream targets.

Signal transducer and activator of transcription (STAT)3 signalling

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

Signal pathways are indicated to convey crucial processes involved in conception, development and progression of pregnancy, such as trophoblast invasion and differentiation. One signalling pathway that draws interest because of its role in reproduction is the JAK–STAT signalling pathway.

The JAK–STAT pathway initially attracted a great deal of attention as a rapidly induced form of signal transduction. It was quickly demonstrated, though, that this pathway is responsible for far more than rapid induction of immunoregulatory signals, but rather, it was also vital for a number of responses, including cell growth, differentiation processes, longevity and migration.97 Especially the STAT3 protein has been described as a candidate with oncogenic potential, because either its expression or activation profile is constitutively higher in a number of malignancies, including those pertaining to the reproductive system or the STAT3-dependent transcription regulatory network is involved in metastatic progression (reviewed in98,99).

In short, cytokine-specific receptors aggregate upon mediator binding leading to the juxtaposition of receptor-associated tyrosine kinases termed Janus kinases or JAKs (named after the two-headed Roman mythological god, Janus, because of its ‘two-headed’ structure). Thus, JAKs can, through cross-phosphorylation, reciprocally activate each other as well as specific cytoplasmic domains of their respective cytokine receptor. Intracellular STATs are now recruited to these receptor domains, with the goal of bringing STATs within vicinity of JAKs so they may also in turn be phosphorylated and activated by the latter. Following activation, STATs disassociate from the receptor ligand and proceed to form homo- and heterodimers that translocate into the cell’s nucleus. Here, STATs influence the transcription of target proteins by binding and manipulating the promoter regions of these proteins. One of the transcribed proteins is the suppressors of cytokine signalling (SOCS) protein, a regulator that is specifically and non-specifically able to negatively modulate the duration of the cytokine signalling response by binding to phosphotyrosine residues as seen for instance on JAKs.100–102

Indeed, STAT3 is a main mediator of several cytokine and growth factor signals that are also relevant for reproduction: IL-6, IL-11, HGF, LIF (cytokines that mediate through gp130) or IL-10.103–105

The fact that Lif (ko) mice are incapable of implantation, although fertile, invites the hypothesis that STAT3 is involved in the process of implantation, possibly through mediation of invasion.106,107 An interesting observation is that STAT3 is expressed in the murine and human pre-implantation stage embryo at as early as the morula stage. Shortly after fertilization, STAT3 expression in the human and murine embryo is polarized, meaning that there are spacial and temporal differences in protein expression among the blastomeres such that by the eight-cell stage, unique cellular domains consisting of STAT3 rich- and poor cell populations are generated. In the morula, it appears that the ‘inner’ cells contain virtually no STAT3, while the ‘outer’ cells contain both rich and poor STAT3 expressing trophoblast. In the blastocyst stage (contrary to the aforementioned, these experiments were undertaken only in mice), STAT3 immunofluorescence was restricted to the trophoblast, but with pronounced differences in intensity, suggesting that expression might be limited to certain trophoblast populations.108

However, targeted gene disruption of the STAT3 protein was detrimental to murine pregnancy shortly after implantation. Stat3 ko embryos degenerated and died in the early post-implantation period on E7.5, while wild-type embryos expressed the protein in the extraembryonic tissues, especially in extraembryonic columnar visceral endoderm (destined to form the visceral wall of the yolk sac), but also including the parietal endoderm, the ectoplacental cone and throughout the extraembryonic ectoderm, suggesting a vital role for STAT3 in early development.109,110 The extraembryonic ectoderm is known to differentiate into the ectoplacental cone from which spongiotrophoblast and giant trophoblast cells originate (reviewed in111). Culture of spongiotrophoblast cells leads to the eventual formation of trophoblast giant cells,112 and trophoblast giant cells are considered the murine correlate to invasive human EVT cells.113 This simultaneously indicates that STAT3 is not exclusively responsible for trophoblast invasion during implantation; however, without STAT3 signalling, the maintenance of pregnancy beyond initial implantation is impossible. Whether this might be because, at least in part, of inadequate post-implantation trophoblast invasion remains speculative.

Chan et al.114 revealed via immunohistochemistry of first trimester placentae that especially serine-activated STAT3 protein is detectable in both cytoplasm and nuclei of syncytiotrophoblast, cytotrophoblast and villous intermediate trophoblast, while this expression profile disappears at term. Serine phosphorylation in trophoblastic cells is mainly mediated via mammalian target of rapamycin.115

Interestingly, expression appears more intensive in the cytotrophoblast and intermediate trophoblast subsets. These are considered the trophoblast responsible for invasion in the placenta, and thus important for placentation and, later, adequate sustenance of the foetus.116,117 The fact that this expression profile is augmented in samples derived from mole pregnancy and gestational trophoblastic disease underscores the idea that STAT3 activation is necessary for the capability of the trophoblast to invade the vicinity.

In comparative experiments between carcinoma cell lines and physiological primary cells from first trimester and term placentae, constitutive activity of STAT3 as seen through elevated DNA binding of STAT3 dimers could be correlated with invasiveness of trophoblast and its derivates.118 Furthermore, it appears that LIF transmits an up-regulation of STAT3 expression, activation and DNA-binding activity, which results ultimately in a protease profile alteration that dose-dependently boosts trophoblastic (human choriocarcinoma) invasion and proliferation.119 Here, cDNA macroarrays found that the expression of TIMP-1 was down-regulated, with TIMP-1 being a protein that binds and thus inactivates MMP-9, or MMP-9, a protein critical for cytotrophoblast invasion.120,121 Knocking down STAT3 expression in Jeg-3 choriocarcinoma cells, first trimester and term placentae trophoblast through short interfering RNA (siRNA) resulted in a dramatic reduction in invasive potential regardless of LIF supplementation.105

LIF is also able to promote the adhesion of first trimester EVT adhesion to an ECM, a process generally accepted as a prerequisite for the differentiation of trophoblast into the invasive phenotype.13 There is some controversy whether LIF has the same effect on invasiveness of physiological trophoblast cells as it has on choriocarcinoma cell lines. LIF has been reported to decrease gelatinase activity in first trimester trophoblast cells,122,123 and the aforementioned work by Tapia et al.13 demonstrated that LIF supplementation of EVT resulted in a higher secretion of TIMP-1 and TIMP-2 as detectable through ELISA. Taken together, these data suggest a largely inhibitory effect on EVT invasion. Whether this discrepancy is because of the differences in cell physiology (primary trophoblast versus choriocarcinoma cell line) or because of differences in utilized concentrations or cytokine stimulation periods has not yet been resolved. It is known, however, that LIF suppresses its own effects by means of negative feedback regulation of the JAK–STAT pathway through SOCS3.124 In this context, both too low and too high levels of LIF in uterine flushings have been suggested to have negative predictive value in implantation success.125,126

In human trophoblast cells, peripheral blood mononuclear cells (PBMC) induced phosphorylation of STAT1 and STAT3,127 and in Jeg-3 choriocarcinoma cells, ablation of Stat3 by siRNA leads to an alteration of gene expression profiles including that of SOCS3, whose gene expression decreased by almost twofold especially after JEG-3 cells were confronted with conditioned medium of activated PBMC.128

In the murine model, deletion of the Socs3 gene leads to embryonically lethal placental insufficiency and a phenotypical placenta that exposes poorly formed spongiotrophoblast and labyrinthine layers, as well as an increase in trophoblast giant cell differentiation similar to placentae of wild-type mice overexposed to LIF (reviewed in129,130). Interestingly, decreased SOCS3 expression is observed especially in the villous tissue of placentae from women with pre-eclampsia,131 and in loose analogy to the Socs3 ko placenta, pre-eclampsia placentae are characterized by shallow invasion of the decidua by the trophoblast, yet with an excess of proliferative immature trophoblast.132 These findings might appear counterintuitive upon initial inspection, because low SOCS3 expression would in turn portend high STAT3 activation, and thus sufficient trophoblast invasion. However, the finding that the expression of the LIF-receptor is abnormally persistent on EVT cells from placental bed biopsies stemming from patients suffering from a combination of early onset pre-eclampsia and intrauterine growth retardation133 only further denotes the importance of LIF and SOCS3 fine-tuning. In conclusion, it seems that the LIF–JAK–STAT–SOCS signalling pathway is involved in many functions of the trophoblast and their derivate cells as can be recognized in murine models, in vitro assays and descriptional studies. The functions that are influenced encompass trophoblast properties such as differentiation, adhesion, migration/invasion, and these characteristics underlie a strictly regulated fine-tuning mechanism (serine versus tyrosine phosphorylation for activation, negative feedback, etc.) that invites further investigation.

Endoglandular trophoblast invasion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

About 2 weeks after fertilization, the subset of EVTs comes into first contact with maternal tissues and starts to invade into the decidual stroma. During this process of migration and invasion, EVTs pass capillaries and glands of the uterine interstitium, finally reaching the myometrium and/or spiral arteries. So far, trophoblast invasion has been described to serve (1) attachment of the placenta to the uterus and (2) transformation of spiral arteries into large open conduits.134 Spiral arteries are first invaded by intravasation of interstitial EVTs,135 then blocked by cells that have passed the media of the vessels and have become endovascular trophoblasts. These plugs of cells remain until the end of the first trimester, and only with the beginning of the second trimester, maternal blood flow through the intervillous space of the placenta is established. Hence, only then is haemotrophic nutrition of the embryo ascertained.136 This has led to the question as to how the embryo gains enough nutrition prior to the onset of maternal blood flow through the placenta, i.e. during the first trimester of pregnancy.

The non-pregnant endometrium, as well as the pregnant decidua, contains huge numbers of uterine glands that open towards the uterine cavity. The glandular secretion products reach the uterine cavity as well as the fallopian tubes and play an essential role in feeding and maintaining the very early embryo prior to implantation.137 The secretion products that contain a mixture of proteins, lipids and carbohydrates do not only play a role in feeding the early embryo but additionally seem to have immunosuppressive features and to be involved in controlling implantation.138

Only recently, it was assumed that glandular secretion products may play a role in nutrition of the human embryo even after implantation. The presence of such secretion products has been demonstrated in the intervillous space of the first trimester placenta.139 These authors have shown that secretory components of the uterine glands are part of the clear fluid found in the intervillous space of a first trimester placenta.139 However, they could not show how the glandular secretion products reach the intervillous space of the placenta. The glandular openings are towards the uterine cavity rather than the intervillous space, and thus so far, it can only be speculated that invasive EVTs might use the uterine glands as targets, similar to the uterine spiral arteries.

Using double immunohistochemical staining for cytokeratin 7 and human leukocyte antigen-G, EVTs were detected in the vicinity of uterine glands and even in very close contact to glandular epithelial cells. In all samples from gestational week 6–11 endoglandular trophoblasts have been perceived, i.e. trophoblasts replacing glandular epithelial cells or present in the lumen of uterine glands.140

Using novel co-culture confrontation model systems with decidual tissues as matrices for trophoblast invasion from villous explants, trophoblast invasion into the decidual interstitium and towards uterine glands has been analysed. Also in these in vitro systems, EVTs invaded the decidual tissues towards the glands and could be detected within the glands.140 These data may provide first evidence for trophoblast invasion into the lining of the glandular epithelium, thus opening the way for glandular secretion products to reach the intervillous space – similar to the pathway of arterial remodelling.

According to the aforementioned data, a new subset of EVT, the ‘endoglandular trophoblast’, can be suggested. Replacement of glandular epithelial cells by endoglandular trophoblasts may provide a possible mechanism for opening and connecting uterine glands towards the intervillous space. This would enable histiotrophic nutrition of the embryo during the first trimester of pregnancy prior to onset of the maternal blood flow. Thus, according to the definition found in Figure 9.3 of Benirschke et al.,141 the different phenotypes of EVT need to be extended to interstitial trophoblast, endovascular trophoblast and endoglandular trophoblast.

Conclusive remarks

  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References

The literature summarized in this review demonstrates that Wnt and STAT3 signalling are main intracellular governors of trophoblast invasiveness and further functions. The large variety of Gals has a strong potential to influence these systems, but most of the current knowledge has been obtained from other cell types than trophoblast. The ECM is simultaneously a multivalent key controller and target of trophoblast invasion. Newest findings suggest that a part of invasive trophoblast cells form a new subtype, the endoglandular trophoblast.


  1. Top of page
  2. Abstract
  3. Introduction
  4. Extracellular matrix (ECM)
  5. Role of galectins in trophoblast invasion
  6. The role of Wnt signalling in trophoblast invasion
  7. Signal transducer and activator of transcription (STAT)3 signalling
  8. Endoglandular trophoblast invasion
  9. Conclusive remarks
  10. References
  • 1
    McEwan M, Lins RJ, Munro SK, Vincent ZL, Ponnampalam AP, Mitchell MD: Cytokine regulation during the formation of the fetal–maternal interface: focus on cell–cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth Factor Rev 2009; 20:241249.
  • 2
    Aplin JD, Haigh T, Lacey H, Chen CP, Jones CJ: Tissue interactions in the control of trophoblast invasion. J Reprod Fertil Suppl 2000; 55:5764.
  • 3
    Snir A, Brenner B, Paz B, Lanir N: Presence of Integrin alpha(IIb)beta3 in early gestation human trophoblasts. Possible involvement of fibrin as a matrix ligand. Thromb Res 2009; [Epub ahead of print].
  • 4
    Damsky CH, Werb Z: Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 1992; 4:772781.
  • 5
    Quenby S, Anim-Somuah M, Kalumbi C, Farquharson R, Aplin JD: Different types of recurrent miscarriage are associated with varying patterns of adhesion molecule expression in endometrium. Reprod Biomed Online 2007; 14:224234.
  • 6
    Staun-Ram E, Goldman S, Shalev E: p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta 2009; 30:10291036.
  • 7
    Bischof P, Meisser A, Campana A: Biochemistry and molecular biology of trophoblast invasion. Ann N Y Acad Sci 2001; 943:157162.
  • 8
    Hannan NJ, Salamonsen LA: CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod 2008; 79:5865.
  • 9
    Staun-Ram E, Goldman S, Gabarin D, Shalev E: Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004; 2:59.
  • 10
    Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL, Fisher SJ: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994; 269:1712517131.
  • 11
    Meisser A, Cameo P, Islami D, Campana A, Bischof P: Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod 1999; 5:10551058.
  • 12
    Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205:194204.
  • 13
    Tapia A, Salamonsen LA, Manuelpillai U, Dimitriadis E: Leukemia inhibitory factor promotes human first trimester extravillous trophoblast adhesion to extracellular matrix and secretion of tissue inhibitor of metalloproteinases-1 and -2. Hum Reprod 2008; 23:17241732.
  • 14
    Staun-Ram E, Shalev E: Human trophoblast function during the implantation process. Reprod Biol Endocrinol 2005; 3:56.
  • 15
    Hirabayashi J, Kasai KI: Evolution of animal lectins. Prog Mol Subcell Biol 1998; 19:4588.
  • 16
    Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM, Wang JL: Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994; 76:597598.
  • 17
    Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F, Kasai K: Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 2002; 1572:232254.
  • 18
    Brewer CF: Lectin cross-linking interactions with multivalent carbohydrates. Adv Exp Med Biol 2001; 491:1725.
  • 19
    Smetana K, Holikova Z, Klubal R, Bovin NV, Dvorankova B, Bartunkova J, Liu FT, Gabius HJ: Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells. J Leukoc Biol 1999; 66:644649.
  • 20
    Jeschke U, Karsten U, Wiest I, Schulze S, Kuhn C, Friese K, Walzel H: Binding of galectin-1 (gal-1) to the Thomsen–Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem Cell Biol 2006; 126:437444.
  • 21
    Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H: Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen–Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007; 28:11651173.
  • 22
    Jeschke U, Reimer T, Bergemann C, Wiest I, Schulze S, Friese K, Walzel H: Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1. Histochem Cell Biol 2004; 121:501508.
  • 23
    Walzel H, Schulz U, Neels P, Brock J: Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett 1999; 67:193202.
  • 24
    Walzel H, Blach M, Hirabayashi J, Arata Y, Kasai K, Brock J: Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. Cell Signal 2002; 14:861868.
  • 25
    Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J: Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 2000; 10:131140.
  • 26
    Fischer I, Schulze S, Kuhn C, Friese K, Walzel H, Markert UR, Jeschke U: Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 2009; 30:10781082.
  • 27
    Van Der Leij J, Van Den Berg A, Blokzijl T, Harms G, Van Goor H, Zwiers P, Van Weeghel R, Poppema S, Visser L: Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 2004; 204:511518.
  • 28
    Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:14501457.
  • 29
    Karimi K, Arck PC: Natural killer cells: keepers of pregnancy in the turnstile of the environment. Brain Behav Immun 2009; [Epub ahead of print].
  • 30
    Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A: Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med 2008; 86:13951406.
  • 31
    Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD: Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 2007; 109:219227.
  • 32
    Sturm A, Lensch M, Andre S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius HJ: Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004; 173:38253837.
  • 33
    Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M, Nakamura Y, Tanaka T: Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004; 429:7275.
  • 34
    Van Den Brule FA, Price J, Sobel ME, Lambotte R, Castronovo V: Inverse expression of two laminin binding proteins, 67LR and galectin-3, correlates with the invasive phenotype of trophoblastic tissue. Biochem Biophys Res Commun 1994; 201:388393.
  • 35
    Crider-Pirkle S, Billingsley P, Faust C, Hardy DM, Lee V, Weitlauf H: Cubilin, a binding partner for galectin-3 in the murine utero–placental complex. J Biol Chem 2002; 277:1590415912.
  • 36
    Bozic M, Petronijevic M, Milenkovic S, Atanackovic J, Lazic J, Vicovac L: Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 2004; 25:797802.
  • 37
    Maquoi E, Van Den Brule FA, Castronovo V, Foidart JM: Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 1997; 18:433439.
  • 38
    Vicovac L, Jankovic M, Cuperlovic M: Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 1998; 13:730735.
  • 39
    Ochieng J, Warfield P: Galectin-3 binding potentials of mouse tumor EHS and human placental laminins. Biochem Biophys Res Commun 1995; 217:402406.
  • 40
    Ideo H, Seko A, Yamashita K: Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 2005; 280:47304737.
  • 41
    Ideo H, Seko A, Yamashita K: Recognition mechanism of galectin-4 for cholesterol 3-sulfate. J Biol Chem 2007; 282:2108121089.
  • 42
    Bernerd F, Sarasin A, Magnaldo T: Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci U S A 1999; 96:1132911334.
  • 43
    Leonidas DD, Vatzaki EH, Vorum H, Celis JE, Madsen P, Acharya KR: Structural basis for the recognition of carbohydrates by human galectin-7. Biochemistry 1998; 37:1393013940.
  • 44
    Demers M, Magnaldo T, St-Pierre Y: A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 2005; 65:52055210.
  • 45
    Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, Andre S, Brinck U, Alken P, Gabius HJ: Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007; 51:681690.
  • 46
    Zick Y, Eisenstein M, Goren RA, Hadari YR, Levy Y, Ronen D: Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J 2004; 19:517526.
  • 47
    Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T: Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology 2003; 13:755763.
  • 48
    Choufani G, Ghanooni R, Decaestecker C, Delbrouck K, Simon P, Schuring MP, Zick Y, Hassid S, Gabius HJ, Kiss R: Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3. Laryngoscope 2001; 111:16561662.
  • 49
    Danguy A, Rorive S, Decaestecker C, Bronckart Y, Kaltner H, Hadari YR, Goren R, Zich Y, Petein M, Salmon I, Gabius HJ, Kiss R: Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 2001; 16:861868.
  • 50
    Bidon N, Brichory F, Bourguet P, Le Pennec JP, Dazord L: Galectin-8: a complex sub-family of galectins (Review). Int J Mol Med 2001; 8:245250.
  • 51
    Popovici RM, Krause MS, Germeyer A, Strowitzki T, Von Wolff M: Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. J Clin Endocrinol Metab 2005; 90:61706176.
  • 52
    Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T: Galectin-9 in physiological and pathological conditions. Glycoconj J 2004; 19:593600.
  • 53
    Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003; 170:36313636.
  • 54
    Chabot S, Kashio Y, Seki M, Shirato Y, Nakamura K, Nishi N, Nakamura T, Matsumoto R, Hirashima M: Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 2002; 12:111118.
  • 55
    Wada J, Kanwar YS, Makino H: Relevance of extracellular matrix and its receptors in mammalian nephrogenesis revealed by metanephric organ culture system. Nephrol Dial Transplant 2002; 17(Suppl. 9):7577.
  • 56
    Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Nishi N, Imaizumi T, Saita N, Toyama Y, Takashima H, Nakamura T, Ohkawa M, Hirashima M: Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002; 169:59125918.
  • 57
    Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, Janaky T, Boronkai A, Kliman H, Meiri H, Bohn H, Than GN, Sumegi B: Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004; 271:10651078.
  • 58
    Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR: Charcot–Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002; 277:1485914868.
  • 59
    Hotta K, Funahashi T, Matsukawa Y, Takahashi M, Nishizawa H, Kishida K, Matsuda M, Kuriyama H, Kihara S, Nakamura T, Tochino Y, Bodkin NL, Hansen BC, Matsuzawa Y: Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity. J Biol Chem 2001; 276:3408934097.
  • 60
    Yang RY, Hsu DK, Yu L, Ni J, Liu FT: Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 2001; 276:2025220260.
  • 61
    Visegrady B, Than NG, Kilar F, Sumegi B, Than GN, Bohn H: Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng 2001; 14:875880.
  • 62
    Than NG, Sumegi B, Than GN, Berente Z, Bohn H: Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot–Leyden crystal protein. Placenta 1999; 20:703710.
  • 63
    Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN: Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J Biol Chem 2002; 277:1491614924.
  • 64
    Stierstorfer B, Kaltner H, Neumuller C, Sinowatz F, Gabius HJ: Temporal and spatial regulation of expression of two galectins during kidney development of the chicken. Histochem J 2000; 32:325336.
  • 65
    French AT, Knight PA, Smith WD, Brown JK, Craig NM, Pate JA, Miller HR, Pemberton AD: Up-regulation of intelectin in sheep after infection with Teladorsagia circumcincta. Int J Parasitol 2008; 38:467475.
  • 66
    Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG: Molecular cloning and characterization of human eosinophil Charcot–Leyden crystal protein (lysophospholipase) Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 1993; 150:456468.
  • 67
    Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006; 127:469480.
  • 68
    Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781810.
  • 69
    Gordon MD, Nusse R: Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006; 281:2242922433.
  • 70
    Hoppler S, Kavanagh CL: Wnt signalling: variety at the core. J Cell Sci 2007; 120:385393.
  • 71
    Sansom OJ, Reed KR, Van De Wetering M, Muncan V, Winton DJ, Clevers H, Clarke AR: Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 2005; 280:2846328467.
  • 72
    He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 1998; 281:15091512.
  • 73
    Wu B, Crampton SP, Hughes CC: Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007; 26:227239.
  • 74
    Fodde R, Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19:150158.
  • 75
    Wang Y: Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 2009; 8:21032109.
  • 76
    Kuhl M: The WNT/calcium pathway: biochemical mediators, tools and future requirements. Front Biosci 2004; 9:967974.
  • 77
    Kim SE, Lee WJ, Choi KY: The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal 2007; 19:511518.
  • 78
    Yun MS, Kim SE, Jeon SH, Lee JS, Choi KY: Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 2005; 118:313322.
  • 79
    Hayashi K, Erikson DW, Tilford SA, Bany BM, Maclean JA 2nd, Rucker EB 3rd, Johnson GA, Spencer TE: Wnt genes in the mouse uterus: potential regulation of implantation. Biol Reprod 2009; 80:9891000.
  • 80
    Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL: Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci U S A 2001; 98:10471052.
  • 81
    Mohamed OA, Jonnaert M, Labelle-Dumais C, Kuroda K, Clarke HJ, Dufort D: Uterine Wnt/beta-catenin signaling is required for implantation. Proc Natl Acad Sci USA 2005; 102:85798584.
  • 82
    Xie H, Tranguch S, Jia X, Zhang H, Das SK, Dey SK, Kuo CJ, Wang H: Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development 2008; 135:717727.
  • 83
    Tulac S, Nayak NR, Kao LC, Van Waes M, Huang J, Lobo S, Germeyer A, Lessey BA, Taylor RN, Suchanek E, Giudice LC: Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 2003; 88:38603866.
  • 84
    Tulac S, Overgaard MT, Hamilton AE, Jumbe NL, Suchanek E, Giudice LC: Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab 2006; 91:14531461.
  • 85
    Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, Genbecev-Krtolica O, Mavrogianis P, Ferrer K, Kruessel J, Fazleabas AT, Fisher SJ, Giudice LC: Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod 2007; 76:102117.
  • 86
    Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R: Wnt3a−/−-like phenotype and limb deficiency in Lef1(−/−)Tcf1(−/−) mice. Genes Dev 1999; 13:709717.
  • 87
    Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen JH, Wainwright BJ: Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996; 122:33433353.
  • 88
    Parr BA, Cornish VA, Cybulsky MI, McMahon AP: Wnt7b regulates placental development in mice. Dev Biol 2001; 237:324332.
  • 89
    He S, Pant D, Schiffmacher A, Meece A, Keefer CL: Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 2008; 26:842849.
  • 90
    Pollheimer J, Loregger T, Sonderegger S, Saleh L, Bauer S, Bilban M, Czerwenka K, Husslein P, Knofler M: Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 2006; 168:11341147.
  • 91
    Sonderegger S, Haslinger P, Sabri A, Leisser C, Otten JV, Fiala C, Knofler M: Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 2010; 151:211220.
  • 92
    Naito AT, Akazawa H, Takano H, Minamino T, Nagai T, Aburatani H, Komuro I: Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ Res 2005; 97:144151.
  • 93
    Sonderegger S, Husslein H, Leisser C, Knofler M: Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007; 28(Suppl. A):S97S102.
  • 94
    Grisaru-Granovsky S, Maoz M, Barzilay O, Yin YJ, Prus D, Bar-Shavit R: Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization. J Cell Physiol 2009; 218:512521.
  • 95
    Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, Morley R, Down T, Beck S, Craig JM, Saffery R: Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 2008; 14:547554.
  • 96
    Rena V, Angeletti S, Panzetta-Dutari G, Genti-Raimondi S: Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells. Placenta 2009; 30:876883.
  • 97
    Bromberg JF: Activation of STAT proteins and growth control. Bioessays 2001; 23:161169.
  • 98
    Ranger JJ, Levy DE, Shahalizadeh S, Hallett M, Muller WJ: Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res 2009; 69:68236830.
  • 99
    Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr: Stat3 as an oncogene. Cell 1999; 98:295303.
  • 100
    Kamura T, Sato S, Haque D, Liu L, Kaelin WG Jr, Conaway RC, Conaway JW: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 1998; 12:38723881.
  • 101
    Hilton DJ: Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55:15681577.
  • 102
    Fitzgerald JS, Poehlmann TG, Schleussner E, Markert UR: Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update 2008; 14:335344.
  • 103
    Suman P, Poehlmann TG, Prakash GJ, Markert UR, Gupta SK: Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J Reprod Immunol 2009; 82:111.
  • 104
    Dubinsky V, Poehlmann TG, Suman P, Gentile T, Markert UR, Gutierrez G: Role of Regulatory and Angiogenic Cytokines in Invasion of Trophoblastic Cells. Am J Reprod Immunol 2010; 63:193199.
  • 105
    Poehlmann TG, Fitzgerald JS, Meissner A, Wengenmayer T, Schleussner E, Friedrich K, Markert UR: Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 2005; 26(Suppl. A):S37S41.
  • 106
    Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121:12831299.
  • 107
    Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359:7679.
  • 108
    Antczak M, Van Blerkom J: Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo. Mol Hum Reprod 1997; 3:10671086.
  • 109
    Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94:38013804.
  • 110
    Duncan SA, Zhong Z, Wen Z, Darnell JE Jr: STAT signaling is active during early mammalian development. Dev Dyn 1997; 208:190198.
  • 111
    Cross JC: Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol 2000; 11:105113.
  • 112
    Carney EW, Prideaux V, Lye SJ, Rossant J: Progressive expression of trophoblast-specific genes during formation of mouse trophoblast giant cells in vitro. Mol Reprod Dev 1993; 34:357368.
  • 113
    Rossant J, Cross JC: Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538548.
  • 114
    Chan HY, Siu MK, Zhang HJ, Wong ES, Ngan HY, Chan KY, Cheung AN: Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices. Histopathology 2008; 53:139146.
  • 115
    Busch S, Renaud SJ, Schleussner E, Graham CH, Markert UR: mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res 2009; 315:17241733.
  • 116
    Kliman HJ: The placenta revealed. Am J Pathol 1993; 143:332336.
  • 117
    Bischof P, Meisser A, Campana A: Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta 2000; 21(Suppl. A):S55S60.
  • 118
    Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR: Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 2003; 50:316321.
  • 119
    Fitzgerald JS, Tsareva SA, Poehlmann TG, Berod L, Meissner A, Corvinus FM, Wiederanders B, Pfitzner E, Markert UR, Friedrich K: Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol 2005; 37:22842296.
  • 120
    Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267:45834591.
  • 121
    Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ: 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437449.
  • 122
    Bischof P, Haenggeli L, Campana A: Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol 1995; 34:225230.
  • 123
    Nachtigall MJ, Kliman HJ, Feinberg RF, Olive DL, Engin O, Arici A: The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: a potential role in human implantation. J Clin Endocrinol Metab 1996; 81:801806.
  • 124
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387:924929.
  • 125
    Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X: The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997; 12:569574.
  • 126
    Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G: Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17:213218.
  • 127
    Jiang K, Chen Y, Jarvis JN: Soluble factors from LPS- and PHA-activated PBMC induce MAPK, Stat1 and Stat3 phosphorylation in primary cultures of human term placental trophoblasts: implications for infection and prematurity. Placenta 2007; 28:538542.
  • 128
    Jiang K, Krous LC, Knowlton N, Chen Y, Frank MB, Cadwell C, Centola M, Jarvis JN: Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach. Placenta 2009; 30:806815.
  • 129
    Boyle K, Robb L: The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J Reprod Immunol 2008; 77:16.
  • 130
    Fitzgerald JS, Toth B, Jeschke U, Schleussner E, Markert UR: Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy. J Reprod Immunol 2009; 83:117123.
  • 131
    Zhao S, Gu Y, Dong Q, Fan R, Wang Y: Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia. Placenta 2008; 29:10241028.
  • 132
    Redline RW, Patterson P: Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26:594600.
  • 133
    Reister F, Kingdom JC, Ruck P, Marzusch K, Heyl W, Pauer U, Kaufmann P, Rath W, Huppertz B: Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR. J Perinat Med 2006; 34:272279.
  • 134
    Huppertz B, Peeters LL: Vascular biology in implantation and placentation. Angiogenesis 2005; 8:157167.
  • 135
    Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69:17.
  • 136
    Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157:21112122.
  • 137
    Burton GJ, Watson AL, Hempstock J, Skepper JN, Jauniaux E: Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 2002; 87:29542959.
  • 138
    Brayman M, Thathiah A, Carson DD: MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004; 2:4.
  • 139
    Burton GJ, Jauniaux E, Charnock-Jones DS: Human early placental development: potential roles of the endometrial glands. Placenta 2007; 28(Suppl. A):S64S69.
  • 140
    Moser G, Gauster M, Orendi K, Glasner A, Theuerkauf R, Huppertz B: Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Hum Reprod (Under revision).
  • 141
    Benirschke K, Kaufmann P, Baergen R: Pathology of the Human Placenta, 5th edn. New York, Springer, 2006.